Home Your basket
• Inverted naso-sinus papil...
   Price 10.50 €
• CT scan, MR imaging and a...
   Price 10.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• Fronto-ethmoidal fibrous ...
   Price 8.50 €
• Description of complicati...
   Price 5.50 €
• Diagnosis and treatment o...
   Price 10.50 €
• Therapeutic choices for c...
   Price 8.50 €
• Bell's palsy: treatment b...
   Price 5.50 €
• Laryngeal tuberculosis....
   Price 8.50 €
• Rhinitis and allergy test...
   Price 8.50 €
• When some clinical cases ...
   Price 8.50 €
• Brain stem cavernous angi...
   Price 8.50 €
• The effects of treatments...
   Price 14.00 €
• Primary sub-mandibular gl...
   Price 8.50 €
• Facial aesthetic lipostru...
   Price 10.50 €
• Botulinum toxin in the lo...
   Price 14.00 €
• A survey of current wound...
   Price 5.50 €
• Surgery of mucocele of th...
   Price 10.50 €
• Hypersensitivity to inhal...
   Price 10.50 €
• Intra-orbital infected cy...
   Price 5.50 €
• Immunohistochemistry expr...
   Price 10.50 €
• Sentinel lymph node biops...
   Price 10.50 €
• Correlation between laryn...
   Price 10.50 €
• Spontaneous cerebrospinal...
   Price 8.50 €
• Papillary carcinoma arisi...
   Price 5.50 €
• Bilateral facial nerve pa...
   Price 5.50 €
• Early evaluation of voice...
   Price 12.00 €
• Dehiscence of the superio...
   Price 10.50 €
• The neurotologic evaluati...
   Price 10.50 €
• Exploration of the swallo...
   Price 14.00 €
• Cochlear implantation in ...
   Price 14.00 €
• Today’s importance of ult...
   Price 14.00 €

Total Order 317.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2011 o

CANCER

Total pharyngolayngectomy in the 21st century: Indica­tions, oncologic and functional outcomes


Authors : Agopian B, Dassonville O, Chamorey E, Poissonnet G, Pierre S, Peyrade F, Hebert C, Benezery K, Viel D, Sudaka A, Vallicioni J, Demard F, Santini J, Bozec A. (Nice)

Ref. : Rev Laryngol Otol Rhinol. 2011;132,4:209-214.

Article published in french
Downloadable PDF document french



Summary : Introduction: The development of laryngeal preservation protocols has considerably modified the indications for total (pharyngo-)laryngectomy (TPL). The objectives of our study are to analyze the current indications for TPL and to evaluate the oncologic and functional outcomes after TPL and their predictive factors. Methods: All patients who underwent TPL for squamous cell carcinoma of the larynx or hypopharynx, at our institution, between 2000 and 2009, were included in this retrospective study. Predictive factors of oncologic and functio­nal outcomes were assessed in univariate and multivariate analyzes. Results: A total of 130 patients were enrolled in our study including 119 men and 11 women, with a mean age of 65.9 years. TPL was realized for salvage in 65 patients. Extra-laryngeal tumor extension (n= 42) was the main indication for TPL in the 65 remaining patients. Overall survival was 49 and 41% at 3 and 5 years respectively. In multivariate analysis, prima­ry tumor site (hypopharynx in comparison to larynx; p= 0.04) has a significant pejorative impact on overall survi­val. Oral alimentation (no enteral nutrition) was recovered successfully by 94% of the patients. In multivariate analysis, primary tumor site (hypopharynx) has a significant pejorative impact on functional results (deglutition: p< 0.0001; phona­tion: p= 0.03). Conclusion: Primary tumor site is one of the main predictive factor of oncologic and functional outcomes after TPL.


Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE